278.76
price down icon1.71%   -4.85
after-market Dopo l'orario di chiusura: 278.76
loading

Amgen Inc Azioni (AMGN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
9.14%
7,447.00
8,196.00 6,903.00 6,986.00 6,105.00
Cost Of Revenue
2.83%
3,200.00
3,112.00 1,806.00 1,813.00 1,720.00
Gross Profit
16.46%
4,247.00
5,084.00 5,097.00 5,173.00 4,385.00
Operating Expenses
14.61%
3,256.00
3,813.00 3,076.00 2,489.00 2,464.00
Benefits Costs and Expenses
2.33%
7,515.00
7,344.00 4,956.00 5,372.00 2,663.00
Costs And Expenses
6.77%
6,456.00
6,925.00 4,882.00 4,302.00 4,184.00
Operating Income/Loss
22.03%
991.00
1,271.00 2,021.00 2,684.00 1,921.00
Nonoperating Income/Loss
158.46%
-235.00
402.00 685.00 -318.00 2,064.00
Income/Loss Before Equity Method Investments
107.98%
-68.00
852.00 1,947.00 1,614.00 3,442.00
Income/Loss From Equity Method Investments
196.43%
27.00
-28.00 14.00 -28.00 31.00
Income/Loss From Continuing Operations Before Tax
107.98%
-68.00
852.00 1,947.00 1,614.00 3,442.00
Income Tax Expense/Benefit
47.06%
45.00
85.00 217.00 235.00 601.00
Income/Loss From Continuing Operations After Tax
114.73%
-113.00
767.00 1,730.00 1,379.00 2,841.00
Net Income/Loss
114.73%
-113.00
767.00 1,730.00 1,379.00 2,841.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
536.00
- 535.00 535.00 534.00
Diluted Average Shares
536.00
- 538.00 537.00 538.00
Basic Earnings Per Share
114.58%
-0.21
1.44 3.23 2.58 5.32
Diluted Earnings Per Share
114.69%
-0.21
1.43 3.22 2.57 5.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
drug_manufacturers_general PFE
$24.86
price up icon 0.24%
drug_manufacturers_general SNY
$48.51
price up icon 1.13%
drug_manufacturers_general BMY
$56.80
price up icon 1.03%
drug_manufacturers_general NVS
$103.04
price down icon 0.02%
drug_manufacturers_general MRK
$96.56
price up icon 0.26%
Capitalizzazione:     |  Volume (24 ore):